Safety and Efficacy of Percutaneous Image-Guided Mediastinal Mass Core-Needle Biopsy

Objective: To retrospectively evaluate the safety and efficacy of percutaneous image-guided mediastinal mass core-needle biopsy. Patients and Methods: Retrospective review of an institutionally maintained biopsy registry identified 337 computed tomography– or ultrasound-guided percutaneous mediastin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Patrick J. Navin, MB, BCh, BAO, Nathan L. Eickstaedt, MD, Thomas D. Atwell, MD, Jason R. Young, MD, Patrick W. Eiken, MD, Brian T. Welch, MD, John J. Schmitz, MD, Grant D. Schmit, MD, Matthew P. Johnson, MS, Michael R. Moynagh, MB, BCh
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/dbf6a85c262847869cbe367aec3ab1e2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dbf6a85c262847869cbe367aec3ab1e2
record_format dspace
spelling oai:doaj.org-article:dbf6a85c262847869cbe367aec3ab1e22021-11-28T04:36:10ZSafety and Efficacy of Percutaneous Image-Guided Mediastinal Mass Core-Needle Biopsy2542-454810.1016/j.mayocpiqo.2021.09.006https://doaj.org/article/dbf6a85c262847869cbe367aec3ab1e22021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2542454821001405https://doaj.org/toc/2542-4548Objective: To retrospectively evaluate the safety and efficacy of percutaneous image-guided mediastinal mass core-needle biopsy. Patients and Methods: Retrospective review of an institutionally maintained biopsy registry identified 337 computed tomography– or ultrasound-guided percutaneous mediastinal mass core needle biopsies between October 2002 and August 2017 in a single quaternary referral center. Mean patient age was 51 (range, 18 to 93) years. Procedural techniques, anticoagulation/antiplatelet therapy, and tumor anatomical characteristics were reviewed. Classification and gradation of complications was based on the Clavien-Dindo system. Diagnostic yield was defined as the ratio of diagnostic biopsy to all biopsies performed. Results: Mean tumor size was 59.2 (range, 10 to 180) mm with 89.9% (n=303) of lesions located in the prevascular (anterior) mediastinum. There was a single major complication (0.3%) of a symptomatic pneumothorax requiring intervention. There were seven (2.1%) minor complications, including three bleeding complications. A transpleural approach was the only variable associated with an increased complication rate (P<.01). Forty-one (12.2%) patients had a biopsy performed while taking an antiplatelet/anticoagulant agent within the therapeutic window, with a single case (0.3%) associated with a minor bleeding complication. Of 18 (5.3%) procedures performed without cessation of anticoagulant/antiplatelet therapy, there were no bleeding complications. Of all 337 biopsies, 322 (95.5%) were diagnostic. None of the analyzed variables were significantly associated with a nondiagnostic biopsy. Conclusion: Image-guided percutaneous core-needle biopsy of mediastinal masses is a safe procedure with high diagnostic yield. Further prospective studies are required to assess the complication profile in higher risk patients.Patrick J. Navin, MB, BCh, BAONathan L. Eickstaedt, MDThomas D. Atwell, MDJason R. Young, MDPatrick W. Eiken, MDBrian T. Welch, MDJohn J. Schmitz, MDGrant D. Schmit, MDMatthew P. Johnson, MSMichael R. Moynagh, MB, BChElsevierarticleMedicine (General)R5-920ENMayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 6, Pp 1100-1108 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Patrick J. Navin, MB, BCh, BAO
Nathan L. Eickstaedt, MD
Thomas D. Atwell, MD
Jason R. Young, MD
Patrick W. Eiken, MD
Brian T. Welch, MD
John J. Schmitz, MD
Grant D. Schmit, MD
Matthew P. Johnson, MS
Michael R. Moynagh, MB, BCh
Safety and Efficacy of Percutaneous Image-Guided Mediastinal Mass Core-Needle Biopsy
description Objective: To retrospectively evaluate the safety and efficacy of percutaneous image-guided mediastinal mass core-needle biopsy. Patients and Methods: Retrospective review of an institutionally maintained biopsy registry identified 337 computed tomography– or ultrasound-guided percutaneous mediastinal mass core needle biopsies between October 2002 and August 2017 in a single quaternary referral center. Mean patient age was 51 (range, 18 to 93) years. Procedural techniques, anticoagulation/antiplatelet therapy, and tumor anatomical characteristics were reviewed. Classification and gradation of complications was based on the Clavien-Dindo system. Diagnostic yield was defined as the ratio of diagnostic biopsy to all biopsies performed. Results: Mean tumor size was 59.2 (range, 10 to 180) mm with 89.9% (n=303) of lesions located in the prevascular (anterior) mediastinum. There was a single major complication (0.3%) of a symptomatic pneumothorax requiring intervention. There were seven (2.1%) minor complications, including three bleeding complications. A transpleural approach was the only variable associated with an increased complication rate (P<.01). Forty-one (12.2%) patients had a biopsy performed while taking an antiplatelet/anticoagulant agent within the therapeutic window, with a single case (0.3%) associated with a minor bleeding complication. Of 18 (5.3%) procedures performed without cessation of anticoagulant/antiplatelet therapy, there were no bleeding complications. Of all 337 biopsies, 322 (95.5%) were diagnostic. None of the analyzed variables were significantly associated with a nondiagnostic biopsy. Conclusion: Image-guided percutaneous core-needle biopsy of mediastinal masses is a safe procedure with high diagnostic yield. Further prospective studies are required to assess the complication profile in higher risk patients.
format article
author Patrick J. Navin, MB, BCh, BAO
Nathan L. Eickstaedt, MD
Thomas D. Atwell, MD
Jason R. Young, MD
Patrick W. Eiken, MD
Brian T. Welch, MD
John J. Schmitz, MD
Grant D. Schmit, MD
Matthew P. Johnson, MS
Michael R. Moynagh, MB, BCh
author_facet Patrick J. Navin, MB, BCh, BAO
Nathan L. Eickstaedt, MD
Thomas D. Atwell, MD
Jason R. Young, MD
Patrick W. Eiken, MD
Brian T. Welch, MD
John J. Schmitz, MD
Grant D. Schmit, MD
Matthew P. Johnson, MS
Michael R. Moynagh, MB, BCh
author_sort Patrick J. Navin, MB, BCh, BAO
title Safety and Efficacy of Percutaneous Image-Guided Mediastinal Mass Core-Needle Biopsy
title_short Safety and Efficacy of Percutaneous Image-Guided Mediastinal Mass Core-Needle Biopsy
title_full Safety and Efficacy of Percutaneous Image-Guided Mediastinal Mass Core-Needle Biopsy
title_fullStr Safety and Efficacy of Percutaneous Image-Guided Mediastinal Mass Core-Needle Biopsy
title_full_unstemmed Safety and Efficacy of Percutaneous Image-Guided Mediastinal Mass Core-Needle Biopsy
title_sort safety and efficacy of percutaneous image-guided mediastinal mass core-needle biopsy
publisher Elsevier
publishDate 2021
url https://doaj.org/article/dbf6a85c262847869cbe367aec3ab1e2
work_keys_str_mv AT patrickjnavinmbbchbao safetyandefficacyofpercutaneousimageguidedmediastinalmasscoreneedlebiopsy
AT nathanleickstaedtmd safetyandefficacyofpercutaneousimageguidedmediastinalmasscoreneedlebiopsy
AT thomasdatwellmd safetyandefficacyofpercutaneousimageguidedmediastinalmasscoreneedlebiopsy
AT jasonryoungmd safetyandefficacyofpercutaneousimageguidedmediastinalmasscoreneedlebiopsy
AT patrickweikenmd safetyandefficacyofpercutaneousimageguidedmediastinalmasscoreneedlebiopsy
AT briantwelchmd safetyandefficacyofpercutaneousimageguidedmediastinalmasscoreneedlebiopsy
AT johnjschmitzmd safetyandefficacyofpercutaneousimageguidedmediastinalmasscoreneedlebiopsy
AT grantdschmitmd safetyandefficacyofpercutaneousimageguidedmediastinalmasscoreneedlebiopsy
AT matthewpjohnsonms safetyandefficacyofpercutaneousimageguidedmediastinalmasscoreneedlebiopsy
AT michaelrmoynaghmbbch safetyandefficacyofpercutaneousimageguidedmediastinalmasscoreneedlebiopsy
_version_ 1718408350457135104